The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
Seattle Genetics completed its IPO
On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…
The Seattle Cancer Care Alliance opened its doors
On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
Holden Cancer Center awarded NCI Comprehensive Center designation
In 2001, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Comprehensive Center designation….
The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
The Lawrence and Idell Weisberg Cancer Treatment Center opened in Farmington Hills
In 2001, the Lawrence and Idell Weisberg Cancer Treatment Center opened in Farmington Hills. It offered an outpatient…
Biotechnology | Dentistry | Life Science News | Non-Profit Research | Oncology | Therapeutics | Veterinary
The University of Minnesota Cancer Center was founded
In 2001, the University of Minnesota Cancer Center, now known as the Masonic Cancer Center, was founded. It…
Siteman Cancer Center researchers showed the immune system helps prevent tumor development
In 2001, Siteman Cancer Center researcher Robert D. Schreiber, Ph.D. and colleagues first showed the immune system helps…
Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer Center
In 2001, the Vanderbilt-Ingram Cancer Center (VICC) earned the National Cancer Institute’s (NCI) highest distinction as a Comprehensive…
Regional Cancer Coalitions of Georgia Created
In 2001, the Regional Cancer Coalitions of Georgia were created by the General Assembly and Governor to ensure…
NCI established the Center to Reduce Cancer Health Disparities
On Dec. 3, 2000, the National Cancer Institute announced it had established the Center to Reduce Cancer Health…
The Radiation Exposure Compensation Amendments of 1999 was signed into law
On Jul. 7, 2010 the Radiation Exposure Compensation Amendments of 1999 (P.L. 106-245) was signed into law. The…
Holden Cancer Center awarded NCI Center designation
In 2000, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Center designation. The…
Dendreon Corporation launched its Initial Public Offering
On Jun. 16, 2000, Dendreon announced its initial public offering of 4,500,000 shares of common stock at $10.00…
A $60 million program was announced to address the unequal burden of cancer within certain special populations in the US
On Apr. 6, 2000, a $60 million program was announced to address the unequal burden of cancer within…
The Supreme Court ruled the FDA does not have authority to regulate tobacco as a drug
On Mar. 21, 2000, the Supreme Court ruled 5 to 4 along ideological lines, that the FDA does…
National Colorectal Cancer Awareness Month was founded
On Feb. 29. 2000, President Clinton officially dedicated March as National Colorectal Cancer Awareness Month. Since then, it…
Stanford researchers first used gene expression profiling to distinguish cancer sub-types
In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…
Georgetown University Hospital became part of MedStar Health
In 2000, the Georgetown University Hospital became part of MedStar Health, a not-for-profit network of seven hospitals in…
Georgetown Lombardi Comprehensive Cancer Center was founded
In 2000, Georgetown Lombardi Comprehensive Cancer Center, was founded when the Georgetown University Medical Center authorized the establishment…
Eli Lilly and Takeda Chemical Industries launched Actos, an oral antidiabetes agent
In 2000, Eli Lilly and Takeda Chemical launched Actos, an oral anti diabetes agent. In 2005, a PROactive…
Fox Chase Cancer Center received Magnet Designation for Nursing Excellence
In 2000, Fox Chase Cancer Center received Magnet Designation for Nursing Excellence from the American Nurses Credentialing Center….
FDA approved Targretin to treat certain T-cell lymphomas
On Dec. 29, 1999, the U.S. Food and Drug Administration (FDA) approved Bexarotene (Targretin) to treat cutaneous T-cell…
The National Cancer Institute published Atlas of Cancer Mortality, 1950-94, showing geographic patterns of cancer death rates across U.S.
On Dec. 8, 1999, the National Cancer Institute published the Atlas of Cancer Mortality, 1950-94, showing the geographic…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Alvin and Ruth Siteman donated $35 to establish the Siteman Cancer Center
On Dec. 2, 1999, Alvin and Ruth Siteman donated $35 million to establish the Alvin J. Siteman Cancer…
The National Cancer Institute awarded nearly $8 million in grants toward Early Detection Research Network
On Nov. 23, 199, the National Cancer Institute awarded nearly $8 million in grants toward the creation of…
NeoPath merged with AutoCyte to create TriPath Imaging
On Jun. 7 1999, NeoPath merged with AutoCyte to form TriPath Imaging based in Burlington, N.C. NeoPath was…
The Study of Tamoxifen and Raloxifene began recruiting volunteers
On May 25, 1999. the Study of Tamoxifen and Raloxifene, or STAR, one of the largest breast cancer…